Company Profile
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Latest News
Fed Meeting, Inflation, Boeing, Meta, Apple, Exxon, and More to Watch This Week
4 Big Tech earnings reports, a Fed meeting, and $100 oil: It's the busiest week of the quarter
Can Humana Beat Q2 Earnings Estimates on Growing Premiums?
Ranking the Best "Magnificent Seven" Stocks to Buy Right Now
Is PATH Broken, Or Just Violently Marked Down?
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Website | https://www.humana.com |
| Audit Risk | 2 |
| Board Risk | 2 |
| Overall Risk | 1 |
| Market Cap | 46.74B |
| Trailing P/E | 41.51 |
| Forward P/E | 24.29 |
| Dividend Rate | 3.54 |
| Dividend Yield | 0.90% |
| Trailing Annual Div. Rate | 3.54 |
| Trailing Annual Div. Yield | 0.90% |
| Trailing EPS | 9.38 |
| Forward EPS | 16.03 |
| Book Value | 154.75 |
| Price-to-Book | 2.52 |
| Enterprise-to-Revenue | 0.29 |
| Enterprise-to-EBITDA | 11.66 |
| Short Ratio | 2.77 |
| Ex-Dividend Date | 06/26/2026 |
| Dividend Date | 07/31/2026 |
| Earnings Date | 07/29/2026 |
| Earnings Call Date | 07/29/2026 |
| Earnings Average | 7 |
| Earnings Low | 1.61 |
| Earnings High | 7.94 |
| Revenue Average | 40.57B |
| Revenue Low | 40.00B |
| Revenue High | 41.30B |